• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

circ-Grm1 通过 FUS 抑制 GRM1 表达促进肺动脉平滑肌细胞增殖和迁移。

circ‑Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS.

机构信息

Department of Pediatrics, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China.

出版信息

Int J Mol Med. 2021 Nov;48(5). doi: 10.3892/ijmm.2021.5035. Epub 2021 Sep 16.

DOI:10.3892/ijmm.2021.5035
PMID:34528696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8480385/
Abstract

Pulmonary arterial hypertension is a progressive and fatal disease. Recent studies suggest that circular RNA (circRNAs/circs) can regulate various biological processes, including cell proliferation. Therefore, it is possible that circRNA may have important roles in pulmonary artery smooth muscle cell proliferation in hypoxic pulmonary hypertension (HPH). The aim of the present study was to determine the role and mechanism of circRNA‑glutamate metabotropic receptor 1 (circ‑Grm1; mmu_circ_0001907) in pulmonary artery smooth muscle cell (PASMC) proliferation and migration in HPH. High‑throughput transcriptome sequencing was used to screen circRNAs and targeted genes involved in HPH. Cell Counting Kit‑8 (CCK‑8), 5‑ethynyl‑2‑deoxyuridine and wound healing assays were employed to assess cell viability and migration. Reverse transcription‑quantitative PCR and western blotting were used to detect target gene expression in different groups. Bioinformatical approaches were used to predict the interaction probabilities of circ‑Grm1 and Grm1 with FUS RNA binding protein (FUS). The interactions of circ‑Grm1, Grm1 and FUS were evaluated using RNA silencing and RNA immunoprecipitation assays. The results demonstrated that circ‑Grm1 was upregulated in hypoxic PASMCs. Further experiments revealed that the knockdown of circ‑Grm1 could suppress the proliferation and migration of hypoxic PASMCs. Transcriptome sequencing revealed that Grm1 could be the target gene of circ‑Grm1. It was found that circ‑Grm1 could competitively bind to FUS and consequently downregulate Grm1. Moreover, Grm1 could inhibit the function of circ‑Grm1 by promoting the proliferative and migratory abilities of hypoxic PASMCs. The results also demonstrated that circ‑Grm1 influenced the biological functions of PASMCs via the Rap1/ERK pathway by regulating Grm1. Overall, the current results suggested that circ‑Grm1 was associated with HPH and promoted the proliferation and migration of PASMCs via suppression of Grm1 expression through FUS.

摘要

肺动脉高压是一种进行性和致命性疾病。最近的研究表明,环状 RNA(circRNA/ circs)可以调节多种生物过程,包括细胞增殖。因此,circRNA 可能在低氧性肺动脉高压(HPH)中的肺动脉平滑肌细胞增殖中发挥重要作用。本研究旨在确定环状 RNA-谷氨酸代谢型受体 1(circ-Grm1; mmu_circ_0001907)在 HPH 中肺动脉平滑肌细胞(PASMC)增殖和迁移中的作用和机制。高通量转录组测序用于筛选 HPH 中涉及的 circRNA 和靶向基因。使用细胞计数试剂盒-8(CCK-8)、5-乙炔基-2-脱氧尿苷和划痕愈合实验评估细胞活力和迁移。逆转录-定量 PCR 和蛋白质印迹法用于检测不同组中靶基因的表达。生物信息学方法用于预测 circ-Grm1 和 Grm1 与 FUS RNA 结合蛋白(FUS)的相互作用概率。使用 RNA 沉默和 RNA 免疫沉淀测定评估 circ-Grm1、Grm1 和 FUS 的相互作用。结果表明,circ-Grm1 在低氧 PASMC 中上调。进一步的实验表明,circ-Grm1 的敲低可抑制低氧 PASMC 的增殖和迁移。转录组测序显示,Grm1 可能是 circ-Grm1 的靶基因。结果发现,circ-Grm1 可以通过与 FUS 竞争结合并进而下调 Grm1 来发挥作用。此外,Grm1 通过促进低氧 PASMC 的增殖和迁移能力来抑制 circ-Grm1 的功能。结果还表明,circ-Grm1 通过调节 Grm1 影响 PASMC 的生物学功能,进而影响 Rap1/ERK 通路。总之,目前的研究结果表明,circ-Grm1 与 HPH 有关,并通过抑制 Grm1 表达通过 FUS 促进 PASMC 的增殖和迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/dd181b176437/IJMM-48-05-05035-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/213c78ae7fa2/IJMM-48-05-05035-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/9074b75260ba/IJMM-48-05-05035-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/cb4b24573ce0/IJMM-48-05-05035-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/24c273eed504/IJMM-48-05-05035-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/42f4feef5759/IJMM-48-05-05035-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/dd181b176437/IJMM-48-05-05035-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/213c78ae7fa2/IJMM-48-05-05035-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/9074b75260ba/IJMM-48-05-05035-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/cb4b24573ce0/IJMM-48-05-05035-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/24c273eed504/IJMM-48-05-05035-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/42f4feef5759/IJMM-48-05-05035-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d4/8480385/dd181b176437/IJMM-48-05-05035-g05.jpg

相似文献

1
circ‑Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS.circ-Grm1 通过 FUS 抑制 GRM1 表达促进肺动脉平滑肌细胞增殖和迁移。
Int J Mol Med. 2021 Nov;48(5). doi: 10.3892/ijmm.2021.5035. Epub 2021 Sep 16.
2
MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.miR-593-5p 通过靶向 PLK1 促进低氧诱导的肺动脉高压的发展。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3495-3502. doi: 10.26355/eurrev_201904_17715.
3
Exosomes derived from hypoxic alveolar epithelial cells promote the phenotypic transformation of pulmonary artery smooth muscle cells via the Rap1 pathway.低氧肺泡上皮细胞来源的外泌体通过 Rap1 通路促进肺动脉平滑肌细胞的表型转化。
Exp Lung Res. 2024;50(1):160-171. doi: 10.1080/01902148.2024.2398994. Epub 2024 Sep 17.
4
Circ- Serves as an Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation.环状 RNA 作为海绵体调节肌球蛋白 10 并促进肺动脉平滑肌增殖。
Hypertension. 2020 Mar;75(3):668-679. doi: 10.1161/HYPERTENSIONAHA.119.13715. Epub 2020 Feb 3.
5
MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.miR-18a-5p 通过靶向 Notch2 促进肺动脉平滑肌细胞的增殖和迁移,从而导致肺动脉高压。
Life Sci. 2020 Sep 15;257:117919. doi: 10.1016/j.lfs.2020.117919. Epub 2020 Jun 22.
6
LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.长链非编码 RNA-SMILR 通过靶向 miR-141 调节 RhoA/ROCK 信号通路,从而调节肺动脉高压中的血管重构。
Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H377-H391. doi: 10.1152/ajpheart.00717.2019. Epub 2020 Jun 19.
7
miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.miR-143 和 miR-145 通过调节 ABCA1 表达促进低氧诱导的肺动脉平滑肌细胞增殖和迁移。
Cardiovasc Pathol. 2018 Nov-Dec;37:15-25. doi: 10.1016/j.carpath.2018.08.003. Epub 2018 Aug 23.
8
Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.ALKBH5 去甲基化酶的缺失通过抑制 Cyp1a1 mRNA 降解缓解低氧诱导的肺动脉高压。
J Mol Cell Cardiol. 2024 Sep;194:16-31. doi: 10.1016/j.yjmcc.2024.05.013. Epub 2024 May 29.
9
circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD.环状结合蛋白转录因子作为 miR-486-5p 的海绵体,调节 CEMIP 并促进 COPD 缺氧肺动脉平滑肌细胞增殖。
Acta Biochim Biophys Sin (Shanghai). 2022 Dec 25;55(3):438-448. doi: 10.3724/abbs.2022178.
10
Circ_0068481 Affects the Human Pulmonary Artery Smooth Muscle Cells' Progression by miR-361-3p/KLF5 Axis.环状 RNA 0068481 通过 miR-361-3p/KLF5 轴影响人肺动脉平滑肌细胞的进展。
Am J Hypertens. 2024 Jan 1;37(1):33-45. doi: 10.1093/ajh/hpad028.

引用本文的文献

1
Role of thrombus-derived exosomal lncRNA LOC101928697 in regulating endothelial function via FUS protein interaction in myocardial infarction.血栓衍生的外泌体长链非编码RNA LOC101928697在心肌梗死中通过与FUS蛋白相互作用调节内皮功能的作用
Sci Prog. 2025 Jul-Sep;108(3):368504251372111. doi: 10.1177/00368504251372111. Epub 2025 Sep 3.
2
Back to the Origin: Mechanisms of circRNA-Directed Regulation of Host Genes in Human Disease.回归本源:环状RNA在人类疾病中对宿主基因的调控机制
Noncoding RNA. 2024 Sep 24;10(5):49. doi: 10.3390/ncrna10050049.
3
Nuclear and cytoplasmic specific RNA binding proteome enrichment and its changes upon ferroptosis induction.

本文引用的文献

1
Hsa_circ_0002062 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells by Regulating the Hsa-miR-942-5p/CDK6 Signaling Pathway.Hsa_circ_0002062通过调控Hsa-miR-942-5p/CDK6信号通路促进肺动脉平滑肌细胞增殖。
Front Genet. 2021 Jul 12;12:673229. doi: 10.3389/fgene.2021.673229. eCollection 2021.
2
Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis.非编码 RNA 作为脓毒症有害心血管效应生物标志物的作用。
Prog Cardiovasc Dis. 2021 Sep-Oct;68:70-77. doi: 10.1016/j.pcad.2021.07.005. Epub 2021 Jul 13.
3
Circle the Cardiac Remodeling With circRNAs.
核和细胞质特异性 RNA 结合蛋白组的富集及其在铁死亡诱导下的变化。
Nat Commun. 2024 Jan 29;15(1):852. doi: 10.1038/s41467-024-44987-9.
4
CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.CircItgb5 通过与 miR-96-5p 和 Uba1 相互作用促进肺动脉平滑肌细胞的合成表型在野百合碱诱导的肺动脉高压。
Respir Res. 2023 Jun 21;24(1):165. doi: 10.1186/s12931-023-02480-9.
5
Insights into circular RNAs: Biogenesis, function and their regulatory roles in cardiovascular disease.环状 RNA 的研究进展:生物发生、功能及其在心血管疾病中的调控作用。
J Cell Mol Med. 2023 May;27(10):1299-1314. doi: 10.1111/jcmm.17734. Epub 2023 Apr 1.
6
Circular RNAs Regulate Vascular Remodelling in Pulmonary Hypertension.环状 RNA 调控肺动脉高压中的血管重构。
Dis Markers. 2022 Nov 3;2022:4433627. doi: 10.1155/2022/4433627. eCollection 2022.
7
Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.癌基因在食管鳞癌中的作用及其治疗潜力。
Clin Transl Oncol. 2023 Mar;25(3):578-591. doi: 10.1007/s12094-022-02981-x. Epub 2022 Oct 31.
8
The Landscape of Noncoding RNA in Pulmonary Hypertension.非编码 RNA 在肺动脉高压中的全景。
Biomolecules. 2022 Jun 7;12(6):796. doi: 10.3390/biom12060796.
9
The role of circular RNAs in pulmonary hypertension.环状 RNA 在肺动脉高压中的作用。
Eur Respir J. 2022 Dec 1;60(6). doi: 10.1183/13993003.00012-2022. Print 2022 Dec.
10
Genome-Wide RNA-Sequencing Reveals Massive Circular RNA Expression Changes of the Neurotransmission Genes in the Rat Brain after Ischemia-Reperfusion.全基因组 RNA 测序揭示了脑缺血再灌注后大鼠脑中神经递质基因的大量环状 RNA 表达变化。
Genes (Basel). 2021 Nov 24;12(12):1870. doi: 10.3390/genes12121870.
用环状RNA圈出心脏重塑。
Front Cardiovasc Med. 2021 Jun 25;8:702586. doi: 10.3389/fcvm.2021.702586. eCollection 2021.
4
Circ_001209 aggravates diabetic retinal vascular dysfunction through regulating miR-15b-5p/COL12A1.环状 RNA 001209 通过调控 miR-15b-5p/COL12A1 加重糖尿病视网膜血管功能障碍。
J Transl Med. 2021 Jul 7;19(1):294. doi: 10.1186/s12967-021-02949-5.
5
Hsa_circ_0008360 sponges miR-186-5p to target CCND2 to modulate high glucose-induced vascular endothelial dysfunction.hsa_circ_0008360 通过海绵吸附 miR-186-5p 靶向 CCND2 调节高糖诱导的血管内皮功能障碍。
Cell Cycle. 2021 Jul;20(14):1389-1401. doi: 10.1080/15384101.2021.1918877. Epub 2021 Jul 5.
6
Circ_0002984 induces proliferation, migration and inflammation response of VSMCs induced by ox-LDL through miR-326-3p/VAMP3 axis in atherosclerosis.环状 RNA 0002984 通过 miR-326-3p/VAMP3 轴诱导 ox-LDL 诱导的 VSMCs 增殖、迁移和炎症反应,参与动脉粥样硬化的发生。
J Cell Mol Med. 2021 Aug;25(16):8028-8038. doi: 10.1111/jcmm.16734. Epub 2021 Jun 25.
7
Circular RNA-HIPK3 regulates human pulmonary artery endothelial cells function and vessel growth by regulating microRNA-328-3p/STAT3 axis.环状RNA-HIPK3通过调控微小RNA-328-3p/信号转导和转录激活因子3轴来调节人肺动脉内皮细胞功能和血管生长。
Pulm Circ. 2021 Mar 29;11(2):20458940211000234. doi: 10.1177/20458940211000234. eCollection 2021 Apr-Jun.
8
Up-regulation of circRNA_0068481 promotes right ventricular hypertrophy in PAH patients via regulating miR-646/miR-570/miR-885.环状 RNA_0068481 通过调控 miR-646/miR-570/miR-885 促进肺动脉高压患者右心室肥厚。
J Cell Mol Med. 2021 Apr;25(8):3735-3743. doi: 10.1111/jcmm.16164. Epub 2021 Mar 12.
9
PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.PBK 通过 ERK/c-Myc 信号通路促进宫颈癌的侵袭表型。
J Cell Physiol. 2021 Apr;236(4):2767-2781. doi: 10.1002/jcp.30134. Epub 2020 Nov 13.
10
Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension.单独使用血栓素受体拮抗剂 NTP42 或与西地那非联合使用在 SuGEN/低氧诱导的肺动脉高压模型中的疗效。
Eur J Pharmacol. 2020 Dec 15;889:173658. doi: 10.1016/j.ejphar.2020.173658. Epub 2020 Oct 27.